BRIEF—Teva launches of generic Viagra tablets in USA

Israeli generics giant Teva Pharmaceutical Industries announced the exclusive launch of its generic Viagra (sildenafil citrate) tablets in the USA.

Viagra is Pfizer’s blockbuster phosphodiesterase-5 (PDE5) inhibitor which is indicated for the treatment of erectile dysfunction (ED).

“The launch of Teva’s sildenafil tablets brings an affordable generic treatment option to the estimated 18 million men in the US who are diagnosed with erectile dysfunction,” said Brendan O’Grady, executive vice president, North America Commercial at Teva, adding: “Our team has made it a priority to ensure that patients are able to access this medicine—through both traditional and more innovative channels.”

Teva is also offering wraparound services to support patients, such as a sildenafil tablets savings card with which people who meet certain requirements are eligible to participate in the program and may pay as little as $0 out-of-pocket with a maximum benefit of up to $100 per fill, for up to six sildenafil tablets prescriptions.

Viagra had annual sales of around $1.4 billion in the USA, according to IMS data as of August 2017.